Generalisability of survival estimates for patients with breast cancer--a comparison across two population-based series. 2006

Johan Lundin, and Tiina Lehtimäki, and Mikael Lundin, and Kaija Holli, and Liisa Elomaa, and Taina Turpeenniemi-Hujanen, and Vesa Kataja, and Jorma Isola, and Heikki Joensuu
Department of Oncology, Helsinki University Central Hospital, Haartmaninkatu 4, P.O.Box 180, FIN-00029 Helsinki, Finland. johan.lundin@helsinki.fi

The purpose of the study was to analyse the generalisability and geographic transportability of survival estimates produced by commonly used prognostic factors. We compared the influence of tumour size, histologic grade, axillary nodal status, oestrogen and progesterone receptor contents, age at diagnosis and two prognostication schemes (the Nottingham Prognostic Index and St. Gallen criteria) in two nationwide cohorts of patients diagnosed with breast cancer in 1991-2, the FinProg (n=2923, Finland) and the SEER series (n=43,249, the United States (US)). Eight-year estimates of breast cancer-specific (84% versus 80%), relative (86% versus 83%), and overall (70% versus 69%) survival were slightly more favourable in the SEER than in the FinProg series, respectively. Despite differences in demographic variables and the frequency of use of adjuvant therapies and mammography screening between the series, the prognostic factors examined produced close to overlapping survival curves with similar shapes. The results suggest that quantitative survival estimates based on frequently used prognostic factors and prognostication schemes are generalisable and transportable between large, unselected cohorts of breast cancer patients.

UI MeSH Term Description Entries
D008327 Mammography Radiographic examination of the breast. 3D-Mammography,Digital Breast Tomosynthesis,Digital Mammography,X-ray Breast Tomosynthesis,3D Mammography,3D-Mammographies,Breast Tomosyntheses, Digital,Breast Tomosyntheses, X-ray,Breast Tomosynthesis, Digital,Breast Tomosynthesis, X-ray,Digital Breast Tomosyntheses,Digital Mammographies,Mammographies,Mammographies, Digital,Mammography, Digital,X ray Breast Tomosynthesis,X-ray Breast Tomosyntheses
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Åland Islands
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015999 Multivariate Analysis A set of techniques used when variation in several variables are studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables. Analysis, Multivariate,Multivariate Analyses

Related Publications

Johan Lundin, and Tiina Lehtimäki, and Mikael Lundin, and Kaija Holli, and Liisa Elomaa, and Taina Turpeenniemi-Hujanen, and Vesa Kataja, and Jorma Isola, and Heikki Joensuu
July 2012, Breast cancer research and treatment,
Johan Lundin, and Tiina Lehtimäki, and Mikael Lundin, and Kaija Holli, and Liisa Elomaa, and Taina Turpeenniemi-Hujanen, and Vesa Kataja, and Jorma Isola, and Heikki Joensuu
January 2022, Frontiers in oncology,
Johan Lundin, and Tiina Lehtimäki, and Mikael Lundin, and Kaija Holli, and Liisa Elomaa, and Taina Turpeenniemi-Hujanen, and Vesa Kataja, and Jorma Isola, and Heikki Joensuu
October 2019, Annals of translational medicine,
Johan Lundin, and Tiina Lehtimäki, and Mikael Lundin, and Kaija Holli, and Liisa Elomaa, and Taina Turpeenniemi-Hujanen, and Vesa Kataja, and Jorma Isola, and Heikki Joensuu
January 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Johan Lundin, and Tiina Lehtimäki, and Mikael Lundin, and Kaija Holli, and Liisa Elomaa, and Taina Turpeenniemi-Hujanen, and Vesa Kataja, and Jorma Isola, and Heikki Joensuu
September 2023, BMC geriatrics,
Johan Lundin, and Tiina Lehtimäki, and Mikael Lundin, and Kaija Holli, and Liisa Elomaa, and Taina Turpeenniemi-Hujanen, and Vesa Kataja, and Jorma Isola, and Heikki Joensuu
January 2014, Asian Pacific journal of cancer prevention : APJCP,
Johan Lundin, and Tiina Lehtimäki, and Mikael Lundin, and Kaija Holli, and Liisa Elomaa, and Taina Turpeenniemi-Hujanen, and Vesa Kataja, and Jorma Isola, and Heikki Joensuu
December 2010, International journal of cancer,
Johan Lundin, and Tiina Lehtimäki, and Mikael Lundin, and Kaija Holli, and Liisa Elomaa, and Taina Turpeenniemi-Hujanen, and Vesa Kataja, and Jorma Isola, and Heikki Joensuu
April 2021, Neuro-oncology,
Johan Lundin, and Tiina Lehtimäki, and Mikael Lundin, and Kaija Holli, and Liisa Elomaa, and Taina Turpeenniemi-Hujanen, and Vesa Kataja, and Jorma Isola, and Heikki Joensuu
January 1986, American journal of epidemiology,
Johan Lundin, and Tiina Lehtimäki, and Mikael Lundin, and Kaija Holli, and Liisa Elomaa, and Taina Turpeenniemi-Hujanen, and Vesa Kataja, and Jorma Isola, and Heikki Joensuu
January 2021, Frontiers in oncology,
Copied contents to your clipboard!